Extensive cross-talk between all ErbB-dependent signalling pathways in HNSCC, as well as the numerous molecular and genetic aberrations present, contribute to the development of cetuximab resistance [30]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.